2016 Emerging Opportunities in the French Sexually-Transmitted Diseases (STD) Diagnostic Testing Market - Profiles Key Suppliers and Potential Market Entrants Developing Innovative Technologies and Products

DUBLIN, Oct. 28, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7rvhd7/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the French Sexually-Transmitted Diseases (STD) Diagnostic Testing Market" report to their offering.

About This Report

This new 280-page report presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for STD testing;
• Profiles key suppliers and potential market entrants developing innovative technologies and products; and
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Companies Mentioned

• Abbott
• Affymetrix
• Beckman Coulter/Danaher
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Cepheid
• Diamedix
• DiaSorin
• Eiken Chemical
• Elitech Group
• Enzo Biochem
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• ID Biomedical/GSK
• Kreatech/Leica
• Lonza
• Ortho-Clinical Diagnostics
• Qiagen
• Roche
• Scienion
• Sequenom
• SeraCare
• Siemens
• Takara Bio
• Thermo Fisher/Life Technology
• Wallac/PE
• Wako

For more information visit http://www.researchandmarkets.com/research/7rvhd7/2016_emerging

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com